Stay updated with breaking news from Nasdaq Fdmt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) traded down 11.7% during mid-day trading on Thursday . The stock traded as low as $16.65 and last traded at $16.80. 88,492 shares changed hands during trading, a decline of 79% from the average session volume of 418,826 shares. The stock had previously closed at […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $20.57, but opened at $16.33. 4D Molecular Therapeutics shares last traded at $15.71, with a volume of 1,208,423 shares trading hands. Analyst Ratings Changes A number of equities research analysts have […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) Director Jacob Chacko sold 5,000 shares of the business’s stock in a transaction on Friday, April 21st. The stock was sold at an average price of $20.05, for a total transaction of $100,250.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) insider Scott Bizily sold 3,750 shares of the firm’s stock in a transaction on Friday, April 21st. The stock was sold at an average price of $20.00, for a total transaction of $75,000.00. Following the completion of the sale, the insider now owns 2,109 shares in the […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 3,120,000 shares, an increase of 19.5% from the March 15th total of 2,610,000 shares. Based on an average daily trading volume, of 355,900 […]